Coelho Rogerio Vivaldi - 08 Jun 2023 Form 4 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
Director
Signature
/s/ Marc Wilson, as attorney-in-fact
Issuer symbol
CRNX
Transactions as of
08 Jun 2023
Net transactions value
+$110,300
Form type
4
Filing time
09 Jun 2023, 08:00:14 UTC
Previous filing
01 Mar 2023
Next filing
21 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common Stock Purchase $110,300 +5,000 $22.06 5,000 08 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $22.06 per share. The range of actual purchase prices on the transaction date was $22.02 to $22.08 per share. Detailed information on the exact number of shares purchased at each price can be obtained from the issuer upon request.